Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.0
-6.54 %
$ 126 M
Market Cap
-2.86
P/E
1. INTRINSIC VALUE
Balance Sheet
OrganiGram Holdings Inc.
| Current Assets | 262 M |
| Cash & Short-Term Investments | 108 M |
| Receivables | 37.2 M |
| Other Current Assets | 118 M |
| Non-Current Assets | 146 M |
| Long-Term Investments | 40.7 M |
| PP&E | 96.2 M |
| Other Non-Current Assets | 8.68 M |
| Current Liabilities | 53.3 M |
| Accounts Payable | 47.1 M |
| Short-Term Debt | 1.09 M |
| Other Current Liabilities | 5.14 M |
| Non-Current Liabilities | 48.5 M |
| Long-Term Debt | 3.37 M |
| Other Non-Current Liabilities | 45.2 M |
EFFICIENCY
Earnings Waterfall
OrganiGram Holdings Inc.
| Revenue | 160 M |
| Cost Of Revenue | 112 M |
| Gross Profit | 47.5 M |
| Operating Expenses | 83.2 M |
| Operating Income | -35.7 M |
| Other Expenses | 9.77 M |
| Net Income | -45.4 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
OrganiGram Holdings Inc.
| Net Income | -45.4 M |
| Depreciation & Amortization | 12.1 M |
| Capital Expenditures | -5.34 M |
| Stock-Based Compensation | 7.18 M |
| Change in Working Capital | 15 M |
| Others | 42.1 M |
| Free Cash Flow | -1.47 M |
Wall Street Analysts Price Targets
OrganiGram Holdings Inc.
OGI has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
OGI does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
OrganiGram Holdings Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Organigram Global Shares Recording of its OG Investor Session
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), Canada's #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. To access a recording of the event please click here or visit www.organigram.ca/investors. “This session was a way for Organigram to engage directly with investors and industry stak.
businesswire.com
- 1 week ago
New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, today released new public opinion data showing strong national support for growing Canada's economy through homegrown industries, including the legal cannabis sector. The national survey, commissioned by Organigram Global and conducted by Abacus Data between April 3–8, 20251, arrives at a pivotal moment for Canada's economic and political futu.
businesswire.com
- 2 weeks ago
Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will gain valuable insights into the Company's growth trajectory, engage directly with leadership on key ind.
businesswire.com
- 1 month ago
Organigram Enters U.S. Through Acquisition of Collective Project Beverages
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Collective Project Limited (“CPL”) for upfront consideration of approximately C$6.2 million, potential milestone payments and potential earnout payments totaling in the aggregate up to C$24M for the twelve-month periods ending September 30, 2025 and Septembe.
businesswire.com
- 1 month ago
Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is proud to announce its official rebrand to Organigram Global Inc. (“Organigram Global”), a move that demonstrates the Company's evolution from an East Coast medical cannabis company into a burgeoning global cannabis leader. Having achieved the number one position in market share in Canada1 and established a growing international footprint, Orga.
businesswire.com
- 1 month ago
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on March 24, 2025 (the “Meeting”). Shareholder Approval of the Name Change and Articles of Amendment At the Meeting, a special resolution approving an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.” (the.
businesswire.com
- 1 month ago
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the T.
businesswire.com
- 2 months ago
Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks
Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales.
seekingalpha.com
- 2 months ago
Organigram Is A Small-Cap Bargain
Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company reported a 17% revenue growth in Q1 FY24, driven by international expansion and the Motif Labs acquisition, despite missing expectations. Organigram's balance sheet is robust with C$46.8 million in cash, no debt, and a healthy current ratio of 3.3X, mitigating many risks.
seekingalpha.com
- 2 months ago
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
On Tuesday, Cannabis producer Organigram Holdings Inc OGI reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million.
benzinga.com
- 2 months ago
Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript
Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
seekingalpha.com
- 2 months ago
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.14 per share a year ago.
zacks.com
- 2 months ago
8. Profile
Summary
OrganiGram Holdings Inc. OGI
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 126 M
Dividend Yield
0.00%
Description
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Contact
35 English Drive, Moncton, NB, E1E 3X3
https://www.organigram.ca
IPO
Date
May 21, 2019
Employees
1093
Officers
Ms. Helen Martin
Chief Legal Officer & Corporate Secretary
Mr. Timothy Emberg
Chief Commercial Officer
Mr. Paolo De Luca C.A., C.F.A
Chief Strategy Officer
Mr. Geoffrey John Riggs
Chief Information Officer
Mr. Gregory Engel
Special Advisor
Max Schwartz
Director of Investor Relations
Ms. Nathalie Batten Kubrick
Executive Vice President of Operations
Mr. Greg Guyatt C.A., CPA
Chief Financial Officer
Ms. Katrina May McFadden
Chief People Officer
Ms. Beena G. Goldenberg
Chief Executive Officer & Director